H. Pandha - Concepedia

Author

H. Pandha

St George's Hospital

Also Known As

H Pandha, H S Pandha, H. PANDHA, H. Pandha, H. S. Pandha, H.S. PANDHA, H.S. Pandha, HS Pandha, Pandha, H, Pandha, H.

Publications

713

Citations

H-Index

Concepts

All Affiliations

St George's Hospital St George's, University of London Institute of Cancer Research St James's University Hospital Mayo Clinic in Arizona

About

H. Pandha is an author at St George's Hospital specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	442
2	Immunology	5	5	378
3	Health Sciences	2	2	29
4	Blood Transplantation	1	1	115
5	Marrow Transplantation	1	1	115

H. Pandha

Publications

510

Citations

H-Index

Page 1

	Year	Citations
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers J. Blake Bartlett, A Michael, Ian Clarke, British Journal of Cancer ImmunologyPathologyRevimid Trade MarkMetronomic ChemotherapyImmunotherapy	2004	139
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over Bhawna Sirohi, R Powles, J Treleaven, Bone Marrow Transplantation Hematological MalignancyTransplantationMarrow TransplantationImmunologyHematology	2000	115
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy Elizabeth J. Ilett, Tim Kottke, Jill Thompson, Gene Therapy Anti-tumour TherapyMedicineImmunologySeparate Oncolytic VirusesImmune Checkpoint Inhibitor	2016	71
Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling Joan Kyula, Aadil Khan, David Mansfield, Oncogene Cancer ImmunosurveillanceMedicinePathogenesisImmunologyMelanoma	2013	43
AN INTERLEUKIN-10 PROMOTER POLYMORPHISM MAY INFLUENCE TUMOR DEVELOPMENT IN RENAL CELL CARCINOMA E.G. Havranek, W. Martin Howell, Helen Fussell, The Journal of Urology	2005	38
PC-SPES: phytotherapy for prostate cancer H. Pandha, RS Kirby The Lancet OncologyUrologyMedicineProstatic Disease	2002	22
Metastatic Extramedullary Plasmacytoma of the Lung J. Wang, H. Pandha, J. Treleaven, Leukemia & lymphoma/Leukemia and lymphoma	1999	20
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo Christine L. White, T Menghistu, Katie Twigger, Gene Therapy Radiation MedicineHealth SciencesRadiation TherapyNitrosative StressMedicine	2007	15
Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC). R. F. Gabitass, N. E. Annels, James Crawshaw, Journal of Clinical Oncology OncologyMurine Cancer ModelsGastrointestinal OncologyInitial MdscsMedicine	2011	14
Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer James Spicer, T.A. Plunkett, Navita Somaiah, Prostate Cancer and Prostatic Diseases UrologySurgical OncologyGenitourinary CancerOral CapecitabineMedicine	2005	13

Page 1